Individualized therapy is long-term cost-effective compared to dose intensification in Crohn's disease patients failing infliximab

C. Steenholdt, J. Brynskov, O. Ø. Thomsen, L. K. Munck, Jan Fallingborg, L. A. Christensen, G. Pedersen, J. Kjeldsen, Bent Ascanius Jacobsen, A. S. Oxholm, J. Kjellberg, M. Ainsworth

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP499
JournalJournal of Crohn's and Colitis
Volume9
Issue numberSuppl. 1
Pages (from-to)S328-S329
ISSN1873-9946
DOIs
Publication statusPublished - 2015
Event10th Congress of ECCO - Barcelona, Spain
Duration: 18 Feb 201521 Feb 2015

Conference

Conference10th Congress of ECCO
Country/TerritorySpain
CityBarcelona
Period18/02/201521/02/2015

Cite this